Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miyabi Ito is active.

Publication


Featured researches published by Miyabi Ito.


Journal of Clinical Microbiology | 2010

Detection of human parechoviruses from clinical stool samples in Aichi, Japan.

Miyabi Ito; Teruo Yamashita; Hideaki Tsuzuki; Yuka Kabashima; Akiko Hasegawa; Satoko Nagaya; Mariko Kawaguchi; Shinichi Kobayashi; Akira Fujiura; Kenji Sakae; Hiroko Minagawa

ABSTRACT Between April 1999 and March 2008, a total of 4,976 stool specimens collected from patients with suspected viral infection through infectious agent surveillance in Aichi, Japan, were tested for the presence of human parechoviruses (HPeVs). We detected HPeVs in 110 samples by either cell culture, reverse transcriptase PCR (RT-PCR), or both. Serotyping either by neutralization test or by nucleotide sequence determination and phylogenetic analysis of the VP1 region and 5′ untranslated region (5′UTR) regions revealed that 63 were HPeV type 1 (HPeV-1), followed by 44 HPeV-3 strains, 2 HPeV-4 strains, and 1 HPeV-6 strain. The high nucleotide and amino acid sequence identities of the Japanese HPeV-3 isolates in 2006 to the strains previously reported from Canada and Netherlands confirmed the worldwide prevalence of HPeV-3 infection. Ninety-seven percent of the HPeV-positive patients were younger than 3 years, and 86.2% younger than 12 months. The clinical diagnoses of HPeV-positive patients were gastroenteritis, respiratory illness, febrile illness, exanthema, “hand, foot, and mouth disease,” aseptic meningitis, and herpangina. Among 49 HPeV-positive patients with gastroenteritis, 35 were positive with HPeV-1 and 12 with HPeV-3, and out of 25 with respiratory illness, 11 were positive with HPeV-1 and 14 with HPeV-3. HPeV-3 seemed to be an important etiological agent of respiratory infection of children. While HPeV-1 was detected predominantly during fall and winter, the majority of the HPeV-3 cases were detected during summer and fall. A different pattern of clinical manifestations as well as seasonality suggested that there are different mechanisms of pathogenesis between HPeV-1 and HPeV-3 infections.


Journal of Clinical Microbiology | 2001

Identification of Aichi Virus Infection by Measurement of Immunoglobulin Responses in an Enzyme-Linked Immunosorbent Assay

Teruo Yamashita; Miyabi Ito; Hideaki Tsuzuki; Kenji Sakae

ABSTRACT Using inhibitory enzyme-linked immunosorbent assay, seroconversions to Aichi virus were detected in 24 (42.9%) of 56 patients with gastroenteritis in six outbreaks. Virus-specific immunoglobulin M (IgM) was detected in convalescent-phase sera from 7 of 24 patients. Of the other 17 patients, 12 developed a significant increase in both IgA and IgG levels and 5 developed a significant increase in IgG alone.


Journal of General Virology | 2010

Molecular identification of enteroviruses including two new types (EV-98 and EV-107) isolated from Japanese travellers from Asian countries.

Teruo Yamashita; Miyabi Ito; Hideaki Tsuzuki; Kenji Sakae; Hiroko Minagawa

Of 58 enterovirus strains isolated from Japanese travellers returning from Asian countries, eight were non-serotypable with existing antisera. By sequencing a part of the VP1 region, six of these strains were typed as echovirus 9, enterovirus (EV)-73, EV-79 or EV-97. The nucleotide identity of the VP1 region of isolate T92-1499 to all enterovirus prototypes was <70 %. The VP1 sequence of isolate TN94-0349 was closely related to coxsackievirus (CV)-A9 (73.3 % nucleotide identity), but the virus could not be neutralized with a serum raised against the prototype CV-A9 strain. On the basis of complete molecular comparisons, T92-1499 and TN94-0349 were identified as EV-98 and EV-107, respectively, by the ICTV Picornavirus Study Group. Serum neutralization tests of Japanese individuals revealed a seroprevalence rate of 11 % for EV-73, and even lower seroprevalence rates, 1.0-3.8 %, were found for the other new enteroviruses, suggesting that prior circulation of these viruses in Japan was unlikely.


Vaccine | 2015

Case-based surveillance enhanced with measles virus detection/genotyping is essential to maintain measles elimination in Aichi Prefecture, Japan

Hiroko Minagawa; Yoshihiro Yasui; Hirokazu Adachi; Miyabi Ito; Emi Hirose; Noriko Nakamura; Mami Hata; Shinichi Kobayashi; Teruo Yamashita

BACKGROUND Japan was verified as having achieved measles elimination by the Measles Regional Verification Commission in the Western Pacific Region in March 2015. Verification of measles elimination implies the absence of continuous endemic transmission. After the last epidemic in 2007 with an estimated 18,000 cases, Japan introduced nationwide case-based measles surveillance in January 2008. Laboratory diagnosis for all suspected measles cases is essentially required by law, and virus detection tests are mostly performed by municipal public health institutes. Despite relatively high vaccination coverage and vigorous response to every case by the local health center staff, outbreak of measles is repeatedly observed in Aichi Prefecture, Japan. METHODS Measles virus N and H gene detection by nested double RT-PCR was performed with all specimens collected from suspected cases and transferred to our institute. Genotyping and further molecular epidemiological analyses were performed with the direct nucleotide sequence data of appropriate PCR products. RESULTS Between 2010 and 2014, specimens from 389 patients suspected for measles were tested in our institute. Genotypes D9, D8, H1 and B3 were detected. Further molecular epidemiological analyses were helpful to establish links between patients, and sometimes useful to discriminate one outbreak from another. All virus-positive cases, including 49 cases involved in three outbreaks without any obvious epidemiological link with importation, were considered as import-related based on the nucleotide sequence information. Chain of transmission in the latest outbreak in 2014 terminated after the third generations, much earlier than the 2010-11 outbreak (6th generations). CONCLUSION Since 2010, almost all measles cases reported in Aichi Prefecture are either import or import-related, based primarily on genotypes and nucleotide sequences of measles virus detected. In addition, genotyping and molecular epidemiological analyses are indispensable to prove the interruption of endemic transmission when the importations of measles are repeatedly observed.


Journal of General Virology | 2004

Isolation and identification of a novel human parechovirus

Miyabi Ito; Teruo Yamashita; Hideaki Tsuzuki; Naokazu Takeda; Kenji Sakae


Journal of General Virology | 2003

Isolation and characterization of a new species of kobuvirus associated with cattle

Teruo Yamashita; Miyabi Ito; Yuka Kabashima; Hideaki Tsuzuki; Akira Fujiura; Kenji Sakae


Japanese Journal of Infectious Diseases | 2005

Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005.

Teruo Yamashita; Miyabi Ito; Akiko Taniguchi; Kennji Sakae


Japanese Journal of Infectious Diseases | 2007

A fatal case of encephalopathy possibly associated with human metapneumovirus infection.

Mami Hata; Miyabi Ito; Shusuke Kiyosawa; Yuri Kimpara; Seidai Tanaka; Teruo Yamashita; Akiko Hasegawa; Shinichi Kobayashi; Norihisa Koyama; Hiroko Minagawa


Journal of Medical Microbiology | 2014

Molecular detection and nucleotide sequence analysis of a new Aichi virus closely related to canine kobuvirus in sewage samples

Teruo Yamashita; Hirokazu Adachi; Emi Hirose; Noriko Nakamura; Miyabi Ito; Yoshihiro Yasui; Shinichi Kobayashi; Hiroko Minagawa


Japanese Journal of Infectious Diseases | 2018

Emergence of New Recombinant Noroviruses GII.P16-GII.2 and GII.P16-GII.4 in Aichi, Japan, during the 2016/17 Season

Mami Hata; Noriko Nakamura; Shinichi Kobayashi; Ayano Onouchi; Tomochika Saito; Emi Hirose; Hirokazu Adachi; Noriko Saito; Miyabi Ito; Yoshihiro Yasui; Masakado Matsumoto; Hiroko Minagawa

Collaboration


Dive into the Miyabi Ito's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Sakae

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar

Noriko Nakamura

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Norihisa Koyama

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naokazu Takeda

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge